LEONABIO INC LONA
COM · Common Stock · CUSIP 04746L203
- SectorHealth care
- IndustryBiological Products, (No Diagnostic Substances)
- HeadquartersBothell, WA
- FilingsSEC EDGAR
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once ($618.0k this quarter). Holder counts are more reliable. Shares outstanding: 3.9m as of 2025-11-05, from the company's own SEC filing; the percentage can still exceed 100%: lent-out shares are counted by the lender and the buyer, and some reports overlap without saying so. Implied quarter-end price ≈ $4.44. Options: 1 managers hold calls ($2.5k notional), 0 hold puts (—).
Trends to Q3 2025
Calls vs puts
Options held, notional value, last 4 quarters. P/C = puts ÷ calls
Numbers
| Quarter | Calls | Puts | P/C |
|---|---|---|---|
| Q4 2024 | $0 | $0 | — |
| Q1 2025 | $0 | $0 | — |
| Q2 2025 | $0 | $0 | — |
| Q3 2025 | $2.5k | $0 | 0.00 |
Biggest buyers
| PERCEPTIVE ADVISORS LLC | New | +540.3k |
| BML Capital Management, LLC | New | +323.1k |
| VANGUARD GROUP INC | New | +153.8k |
| Propel Bio Management, LLC | New | +149.3k |
| Simplify Asset Management Inc. | New | +149.3k |
| TANG CAPITAL MANAGEMENT LLC | New | +60.0k |
| RENAISSANCE TECHNOLOGIES LLC | New | +51.9k |
| ACADIAN ASSET MANAGEMENT LLC | New | +40.2k |
| Pathstone Holdings, LLC | New | +38.6k |
| BlackRock, Inc. | New | +37.6k |
Biggest sellers
| None |
Biggest calls
| GROUP ONE TRADING LLC | New | $2.5k600 shares |
Biggest puts
| None |
Options at notional value: the value of the shares the contracts control, as filers report them, not what the options cost. Not included in the holders, shares or buying above.
Major shareholders (over 5%)
Anyone who owns more than 5% of a class of the company's shares has to say so: on Schedule 13D if they may try to influence or control the company, on 13G if they're a passive investor, and update it as the stake changes. Each holder's latest filing, from 19 Dec 2024 on; percentages are of the share class, as the holder worked them out.
| Holder | Stake |
|---|---|
Sermonix Pharmaceuticals, Inc.
13D · may seek influence
-11.8 pts · filed 2026-10-28
Stated purposeThe assignment of the remaining prefunded warrant rights to acquire 2,352,932 common shares of Issuer effects the previously disclosed distribution-in-kind to PXV II as part of the plan of distribution to the owners of Sermonix's common stock as described in the original Schedule 13D and Item 5. Full filing |
25.1% |
| PERCEPTIVE ADVISORS LLC 13D · may seek influence no change · filed 2026-10-26 | 20.0% |
| ACORN BIOVENTURES, L.P. 13G · passive investor filed 2026-08-20 | 12.1% |
| ADAR1 Capital Management, LLC 13G · institution new · filed 2026-05-15 | 7.7% |
Fell to 5% or below in the last year: Baselake Partners, LP (1.9%, 2026-02-06)
Insider purchases and sales in Q3 2025
Shares bought or sold by the company's own officers, directors and 10% owners, in the open market or privately, as they reported to the SEC on Form 4 (due within two business days of the trade). Grants, option exercises, shares withheld for tax and gifts aren't included.
Officers and directors buying vs selling
Number of people, by quarter (10% owners not included)
Numbers
| Quarter | Buying | Bought | Selling | Sold | Sold under a plan |
|---|---|---|---|---|---|
| Q4 2023 | 1 | $1.5m | 0 | — | — |
| Q1 2024 | 0 | — | 5 | $24.6k | — |
| Q2 2024 | 1 | $100.2k | 0 | — | — |
| Q3 2024 | 0 | — | 5 | $5.0k | — |
| Q4 2024 | 0 | — | 0 | — | — |
| Q1 2025 | 0 | — | 5 | — | — |
| Q2 2025 | 0 | — | 0 | — | — |
| Q3 2025 | 0 | — | 5 | — | — |
| Date | Insider | Trade | Value |
|---|---|---|---|
| 2025-07-01 | Renninger Robert SVP, Finance and Accounting | Sold | —2.9k shares |
| 2025-07-01 | Worthington Mark General Counsel and CCO | Sold | —8.5k shares |
| 2025-07-01 | San Martin Javier CHIEF MEDICAL OFFICER | Sold | —10.8k shares |
| 2025-07-01 | Litton Mark James President and CEO, director | Sold | —25.1k shares |
| 2025-07-01 | CHURCH KEVIN CHIEF SCIENTIFIC OFFICER | Sold | —8.5k shares |
Their holding: how much the trade added to or took from the insider's holding (direct, or the trust or fund named). The same trade is sometimes reported by more than one insider, such as a fund and the director who represents it; totals count it once. A value is left blank where the reported price is far from the market price (usually a typo).
Holders, Q3 2025
| Manager | Shares | Change |
|---|---|---|
| PERCEPTIVE ADVISORS LLC 0.06% of their portfolio | 540.3k $2.2m | New |
| BML Capital Management, LLC 1.23% of their portfolio | 323.1k $1.3m | New |
| VANGUARD GROUP INC 0.00% of their portfolio | 153.8k $636.7k | New |
| Simplify Asset Management Inc. 0.01% of their portfolio | 149.3k $618.0k | New |
| Propel Bio Management, LLC 0.62% of their portfolio | 149.3k $618.0k | New |
| TANG CAPITAL MANAGEMENT LLC 0.01% of their portfolio | 60.0k $248.4k | New |
| RENAISSANCE TECHNOLOGIES LLC 0.00% of their portfolio | 51.9k $215.0k | New |
| ACADIAN ASSET MANAGEMENT LLC 0.00% of their portfolio | 40.2k $165.0k | New |
| Pathstone Holdings, LLC 0.00% of their portfolio | 38.6k $159.8k | New |
| BlackRock, Inc. 0.00% of their portfolio | 37.6k $155.8k | New |
| CITADEL ADVISORS LLC 0.00% of their portfolio | 34.0k $140.7k | New |
| BANK OF AMERICA CORP /DE/ 0.00% of their portfolio | 32.6k $135.0k | New |
| GEODE CAPITAL MANAGEMENT, LLC 0.00% of their portfolio | 30.6k $126.7k | New |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP 0.00% of their portfolio | 21.0k $86.9k | New |
| TWO SIGMA ADVISERS, LP 0.00% of their portfolio | 14.9k $61.5k | New |
| STATE STREET CORP 0.00% of their portfolio | 10.7k $44.5k | New |
| Laird Norton Wetherby Trust Company, LLC 0.01% of their portfolio | 10.1k $41.8k | New |
| Focus Partners Wealth 0.00% of their portfolio | 8.4k $558.1k | New |
| OSAIC HOLDINGS, INC. 0.00% of their portfolio | 7.0k $29.6k | New |
| Tower Research Capital LLC (TRC) 0.00% of their portfolio | 638 $2.6k | New |
| MORGAN STANLEY 0.00% of their portfolio | 510 $2.1k | New |
| American Capital Advisory, LLC 0.00% of their portfolio | 200 $828 | New |
| ROTHSCHILD INVESTMENT LLC 0.00% of their portfolio | 150 $621 | New |
| UBS Group AG 0.00% of their portfolio | 144 $596 | New |
| McIlrath & Eck, LLC 0.00% of their portfolio | 82 $339 | New |
| US BANCORP \DE\ 0.00% of their portfolio | 81 $335 | New |
| ROYAL BANK OF CANADA 0.00% of their portfolio | 67 $0 | New |
| Global Retirement Partners, LLC 0.00% of their portfolio | 52 $215 | New |
| JONES FINANCIAL COMPANIES LLLP 0.00% of their portfolio | 33 $127 | New |
| JPMORGAN CHASE & CO 0.00% of their portfolio | 24 $100 | New |
| BNP PARIBAS FINANCIAL MARKETS 0.00% of their portfolio | 23 $95 | New |
| SBI Securities Co., Ltd. 0.00% of their portfolio | 22 $91 | New |
| BARCLAYS PLC 0.00% of their portfolio | 7 $29 | New |
| CITIGROUP INC 0.00% of their portfolio | 1 $4 | New |